The impact of ayahuasca on suicidality: results from a randomized controlled trial (2019)
- Authors:
- Autor USP: HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2019.01325
- Subjects: ALUCINOGÊNICOS; SUICÍDIO; MORTE
- Keywords: Suicidality; Ayahuasca; Psychedelics; Randomized controlled trial; Novel intervention
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 10, art. 1325 [10] p., 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ZEIFMAN, Richard J. et al. The impact of ayahuasca on suicidality: results from a randomized controlled trial. Frontiers in Pharmacology, v. 10, p. art. 1325 [10] , 2019Tradução . . Disponível em: https://doi.org/10.3389/fphar.2019.01325. Acesso em: 25 fev. 2026. -
APA
Zeifman, R. J., Palhano-Fontes, F., Hallak, J. E. C., Arcoverde, E., Maia-Oliveira, J. P., & Araujo, D. B. (2019). The impact of ayahuasca on suicidality: results from a randomized controlled trial. Frontiers in Pharmacology, 10, art. 1325 [10] . doi:10.3389/fphar.2019.01325 -
NLM
Zeifman RJ, Palhano-Fontes F, Hallak JEC, Arcoverde E, Maia-Oliveira JP, Araujo DB. The impact of ayahuasca on suicidality: results from a randomized controlled trial [Internet]. Frontiers in Pharmacology. 2019 ; 10 art. 1325 [10] .[citado 2026 fev. 25 ] Available from: https://doi.org/10.3389/fphar.2019.01325 -
Vancouver
Zeifman RJ, Palhano-Fontes F, Hallak JEC, Arcoverde E, Maia-Oliveira JP, Araujo DB. The impact of ayahuasca on suicidality: results from a randomized controlled trial [Internet]. Frontiers in Pharmacology. 2019 ; 10 art. 1325 [10] .[citado 2026 fev. 25 ] Available from: https://doi.org/10.3389/fphar.2019.01325 - Psychotic syndrome secondary to meningioma treated with a low dose of olanzapine. [Carta]
- Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ?
- Disorganized symptoms predicted worse functioning outcome in schizophrenia patients with established illness
- Transtorno de pânico e outros medicamentos
- Psychedelics and Personality
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- Nitric oxide’s involvement in the spectrum of psychotic disorders
- Effects of the natural β-carboline alkaloid harmine, a main constituent of Ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies
- An overview of animal models related to schizophrenia
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Informações sobre o DOI: 10.3389/fphar.2019.01325 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002992213.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
